Researchers in health and education are leading a new trial that aims to reduce patients’ dependency on strong pain killers. South Tees Hospitals NHS Foundation Trust and the University of Warwick have developed a support programme that they hope will help people with long term pain reduce their dependency on opioids and improve their quality of life.
Researchers from The James Cook University Hospital in Middlesbrough are appealing for families of children born prematurely, or with conditions such as asthma, diabetes, Down’s syndrome and cerebral palsy, to take part in a national study. James Cook is participating in the University of Oxford’s ARCHIE study, which is looking at whether early antibiotic treatment may prevent these ‘at risk’ children from becoming more unwell when they get flu. The research is funded by the National Institute of Health Research.
South Tees Hospitals NHS Foundation Trust continue to build on their successful record for patient-centred research, development and innovation by leading a pioneering trial which could, ultimately, be used as a first line to detect osteoporosis. In their latest partnership with IBEX Innovations Limited (IBEX), €1.6million has been secured from the European Union’s Horizon 2020 research and innovation programme to investigate the effectiveness of their equipment, which can pick up bone density information alongside conventional X-ray images.
A surgeon-led clinic for people with a neck lump and immediate access to CT scans are amongst the new developments at Teesside’s biggest hospital, which could help speed up the diagnosis of head and neck cancers. A wide variety of specialists including radiologists, pathologists, ear nose and throat specialists and the Oral MaxilloFacial specialists worked together on the potential solutions to provide access to quicker diagnosis and treatment during an innovative workshop at South Tees Institute of Learning, Research and Innovation (LRI), on The James Cook University Hospital site.
A massive “thank you” is being issued to 3,457 patients and more than 200 staff, after South Tees Hospitals NHS Foundation Trust enjoyed a record year in Research & Development. The year 2016 to 2017 became South Tees Hospitals NHS Foundation Trust’s most successful in R&D to date, as the Trust boasted a 17% increase in the number of patients taking part in clinical trials compared with the previous year.
A County Durham woman who has been battling ovarian cancer for more than five years has become the first in the UK to benefit from a new drug to prevent a recurrence of the disease. The 46-year-old, who does not want to be named, is a patient of Dr Talal Mansy, a consultant medical oncologist at The James Cook University Hospital in Middlesbrough.